Corpus Intelligence IC Memo — UMMC-GRENADA 2026-04-26 03:51 UTC
IC Memo — UMMC-GRENADA
Investment Committee Memorandum | MS | 49 beds | Grade C | EBITDA uplift $4.7M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

UMMC-GRENADA

CCN 250168 | GRENADA, MS | 49 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

UMMC-GRENADA is a 49-bed suburban community hospital in GRENADA, MS with $63.7M in net patient revenue and a 7.1% operating margin. The hospital serves a payer mix of 35.2% Medicare, 16.3% Medicaid, and 48.5% commercial.

Thesis: Turnaround. Our ML models identify $4.7M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 7.1% to 14.5% (+736bps).

Net Revenue HCRIS$63.7M
Current EBITDA COMPUTED$4.5M
Operating Margin COMPUTED7.1%
Occupancy HCRIS46.0%
Revenue / Bed COMPUTED$1.3M
Net-to-Gross HCRIS35.6%
Distress Probability ML52.8%

2. Market Context & Competitive Position

110
MS Hospitals
-12.5%
State Median Margin
62
Comparable Hospitals

MS has 110 Medicare-certified hospitals with a median operating margin of -12.5%. The target's margin of 7.1% places it above the state median. Among 62 size-comparable peers (24-98 beds), the median margin is -12.2%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (24-98), prioritizing same-state peers. 62 hospitals in the comp set.

HospitalStateBedsRevenueMargin
UMMC-GRENADA (Target)MS49$63.7M7.1%
SOUTHWEST MS REGIONAL MED CENTMS97$123.1M-16.0%
BAPTIST MEM HOSPITAL UNION COUMS83$117.9M3.7%
METHODIST H/C OLIVE BRANCH HOSMS65$75.4M-25.6%
NORTH SUNFLOWER COUNTY HOSPITAMS25$70.1M-7.2%
MISSISSIPPI METHODIST REHAB CEMS31$68.1M-0.5%
OKTIBBEHA COUNTY HOSPITALMS88$63.2M-16.5%
NESHOBA COUNTY GENERAL HOSPITAMS38$47.6M-19.7%
ALLIANCE HEALTH CENTERMS79$46.1M32.5%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $4.7M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$1.3M+210bp18mo
Cost to Collect4.5%2.5%$1.3M+200bp12mo
Denial Rate Reduction12.0%6.5%$1.3M+198bp12mo
A/R Days Reduction5200.0%3800.0%$775K+122bp9mo
Clean Claim Rate88.0%96.0%$41K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$1.3M
Cost to Collect
$1.3M
Denial Rate Reduction
$1.3M
A/R Days Reduction
$775K
Clean Claim Rate
$41K
Total EBITDA Uplift$4.7M
Current EBITDA$4.5M
+ RCM Uplift+$4.7M
Pro Forma EBITDA$9.2M
Current Margin7.1%
Pro Forma Margin14.5%
WC Released (1x)$2.4M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$7.0M$76.7M11.02x61.6%
Base (11x exit)10.0x11.0x$7.0M$86.6M12.45x65.6%
Bull Case9.0x11.0x$6.3M$104.4M16.66x75.5%
Bull (12x exit)9.0x12.0x$6.3M$115.7M18.47x79.2%
Bear Case11.0x10.0x$7.7M$51.0M6.66x46.1%
Bear (11x exit)11.0x11.0x$7.7M$58.6M7.65x50.2%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighElevated distress probabilityModel estimates 52.8% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 62 hospitals with 24-98 beds
  • Same-state prioritization (n=63)
  • Comp margins: P25=-22.4% / P50=-12.2% / P75=0.5%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.